Jul 24, 2017 8:30am EDT iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital
Jun 05, 2017 8:30am EDT iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference
Jan 27, 2017 8:30am EST Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action
Sep 29, 2016 8:30am EDT iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd
Jul 05, 2016 8:31am EDT iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate
